A comparative study of two regimens of combination chemotherapy in acute leukemia
- PMID: 13596417
A comparative study of two regimens of combination chemotherapy in acute leukemia
Similar articles
-
The influence of chemotherapy on survival in acute leukemia. 3. A comparison of patients treated during 1958-1964 with those treated in two sequentially preceding periods.Blood. 1966 Apr;27(4):490-8. Blood. 1966. PMID: 5931582 No abstract available.
-
Combination chemotherapy in acute leukemia in childhood: corticosteroids, 6-mercaptopurine, and folic acid antagonists.Am J Pharm Sci Support Public Health. 1961 Dec;133:422-30. Am J Pharm Sci Support Public Health. 1961. PMID: 14496653 No abstract available.
-
Observations on the effect of various folic acid antagonists on acute leukemia.Blood. 1951 Nov;6(11):1002-12. Blood. 1951. PMID: 14869362 No abstract available.
-
II. Chemotherapeutic management of monocytic leukemia (1958-1966): a review.South Med J. 1968 May;61(5):535-8. doi: 10.1097/00007611-196805000-00022. South Med J. 1968. PMID: 4869886 Review. No abstract available.
-
Treatment of acute leukemia.Semin Hematol. 1969 Jul;6(3):271-319. Semin Hematol. 1969. PMID: 4895980 Review. No abstract available.
Cited by
-
Interpreting Randomized Controlled Trials.Cancers (Basel). 2023 Sep 22;15(19):4674. doi: 10.3390/cancers15194674. Cancers (Basel). 2023. PMID: 37835368 Free PMC article. Review.
-
Emil "Tom" Frei III, MD (1924-2013).Indian J Med Paediatr Oncol. 2014 Jan;35(1):111-6. Indian J Med Paediatr Oncol. 2014. PMID: 25006300 Free PMC article. No abstract available.
-
Clinical trials in the era of personalized oncology.CA Cancer J Clin. 2011 Nov-Dec;61(6):365-81. doi: 10.3322/caac.20135. Epub 2011 Oct 27. CA Cancer J Clin. 2011. PMID: 22034206 Free PMC article.
-
Rational combinations of targeted cancer therapies: background, advances and challenges.Nat Rev Drug Discov. 2023 Mar;22(3):213-234. doi: 10.1038/s41573-022-00615-z. Epub 2022 Dec 12. Nat Rev Drug Discov. 2023. PMID: 36509911 Review.
-
Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.Mol Oncol. 2022 May;16(10):1969-1985. doi: 10.1002/1878-0261.13150. Epub 2021 Dec 20. Mol Oncol. 2022. PMID: 34866317 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources